Chronic obstructive bronchitis: cell death enzyme RIPK1 is the disease driver

被引：0
|
作者：
Lorenz, Judith
机构：
来源：
PNEUMOLOGIE | 2023年 / 77卷 / 11期
关键词：
D O I：
10.1055/a-2111-0887
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
Das Enzym RIPK1 (Receptor-Interacting Protein Kinase 1) reguliert den Zelltod: Es bestimmt daruber, ob eine Zelle uberlebt oder ob sie Kinase-abhangig einer Apoptose oder aber einer inflammatorisch-lytischen Nekroptose unterlauft. Welche Rolle die RIPK1-Aktivierung bei der Pathogenese der COPD (Chronic Obstructive Pulmonary Disease) spielt, untersuchte eine belgische Arbeitsgruppe in Zusammenarbeit mit weiteren internationalen Forschenden.
引用
收藏
页码：848 / 848
页数：1
相关论文
共 50 条
  • [21] Tyrosine phosphorylation regulates RIPK1 activity to limit cell death and inflammation
    Tu, Hailin
    Xiong, Weihang
    Zhang, Jie
    Zhao, Xueqiang
    Lin, Xin
    NATURE COMMUNICATIONS, 2022, 13 (01)
  • [22] RIPK1 is a key factor in black carbon-induced cell death
    Xu, Xianyan
    Xu, Zhaojun
    Zeng, Shiyong
    Ouyang, Yuhui
    BIOMEDICAL RESEARCH-TOKYO, 2022, 43 (01): : 23 - 30
  • [23] TWEAK and RIPK1 mediate a second wave of cell death during AKI
    Martin-Sanchez, Diego
    Fontecha-Barriuso, Miguel
    Carrasco, Susana
    Dolores Sanchez-Nino, Maria
    von Massenhausen, Anne
    Linkermann, Andreas
    Cannata-Ortiz, Pablo
    Ruiz-Ortega, Marta
    Egido, Jesus
    Ortiz, Alberto
    Belen Sanz, Ana
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2018, 115 (16) : 4182 - 4187
  • [24] Regulation of RIPK1 Phosphorylation: Implications for Inflammation, Cell Death, and Therapeutic Interventions
    Du, Jingchun
    Wang, Zhigao
    BIOMEDICINES, 2024, 12 (07)
  • [25] Metabolic orchestration of cell death by AMPK-mediated phosphorylation of RIPK1
    Zhang, Tao
    Xu, Daichao
    Trefts, Elijah
    Lv, Mingming
    Inuzuka, Hiroyuki
    Song, Guobin
    Liu, Min
    Lu, Jianlin
    Liu, Jianping
    Chu, Chen
    Wang, Min
    Wang, Huibing
    Meng, Huyan
    Liu, Hui
    Zhuang, Yuan
    Xie, Xingxing
    Dang, Fabin
    Guan, Dongxian
    Men, Yuqin
    Jiang, Shuwen
    Jiang, Cong
    Dai, Xiaoming
    Liu, Jing
    Wang, Zhen
    Yan, Peiqiang
    Wang, Jingchao
    Tu, Zhenbo
    Babuta, Mrigya
    Erickson, Emily
    Hillis, Alissandra L.
    Dibble, Christian C.
    Asara, John M.
    Szabo, Gyongy
    Sicinski, Piotr
    Miao, Ji
    Lee, Yu-Ru
    Pan, Lifeng
    Shaw, Reuben J.
    Yuan, Junying
    Wei, Wenyi
    SCIENCE, 2023, 380 (6652) : 1372 - 1380
  • [26] The role of RIPK1 mediated cell death in acute on chronic liver failure (vol 13, 416, 2022)
    Kondo, Takayuki
    Macdonald, Stewart
    Engelmann, Cornelius
    Habtesion, Abeba
    Macnaughtan, Jane
    Mehta, Gautam
    Mookerjee, Rajeshwar P.
    Davies, Nathan
    Pavesi, Marco
    Moreau, Richard
    Angeli, Paolo
    Arroyo, Vicente
    Andreola, Fausto
    Jalan, Rajiv
    CELL DEATH & DISEASE, 2022, 13 (04)
  • [27] Necrostatin-1 blocks both RIPK1 and IDO: consequences for the study of cell death in experimental disease models
    Vandenabeele, P.
    Grootjans, S.
    Callewaert, N.
    Takahashi, N.
    CELL DEATH AND DIFFERENTIATION, 2013, 20 (02): : 185 - 187
  • [28] Necrostatin-1 blocks both RIPK1 and IDO: consequences for the study of cell death in experimental disease models
    P Vandenabeele
    S Grootjans
    N Callewaert
    N Takahashi
    Cell Death & Differentiation, 2013, 20 : 185 - 187
  • [29] Emerging Roles for RIPK1 and RIPK3 in Pathogen-Induced Cell Death and Host Immunity
    Saleh, Danish
    Degterev, Alexei
    APOPTOTIC AND NON-APOPTOTIC CELL DEATH, 2017, 403 : 37 - 75
  • [30] The role and mechanism of RIPK1 in vascular endothelial dysfunction in chronic kidney disease
    Wang, Cheng
    Chen, Huimin
    Su, Hong
    Sheng, Qinghao
    Lang, Yating
    Yu, Qun
    Lv, Zhimei
    Wang, Rong
    FASEB JOURNAL, 2024, 38 (02):
12345